Lipopolysaccharide Binding Protein (LBP) Peptide
LBP
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all LBP products
- LBP (Lipopolysaccharide Binding Protein (LBP))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- FLKPGKVKVE LKESKVGLFN AELLEALLNY YILNTFYPKF NDKLAEGFPL
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of LBP antibody,
Alternative Names: LBP control peptide, LBP antibody Blocking Peptide, Anti-LBP Blocking Peptide, Lipopolysaccharide Binding Protein Blocking Peptide, MGC22233 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- LBP (Lipopolysaccharide Binding Protein (LBP))
- Synonyms
- BPIFD2 Peptide, Bpifd2 Peptide, Ly88 Peptide, LPSBP Peptide, LBP Peptide, lipopolysaccharide binding protein Peptide, lipopolysaccharide-binding protein Peptide, LBP Peptide, Lbp Peptide, LOC100472839 Peptide
- Background
- LBP is involved in the acute-phase immunologic response to gram-negative bacterial infections. Gram-negative bacteria contain a glycolipid, lipopolysaccharide (LPS), on their outer cell wall. Together with bactericidal permeability-increasing protein (BPI), the protein binds LPS and interacts with the CD14 receptor, probably playing a role in regulating LPS-dependent monocyte responses.
- Molecular Weight
- 51 kDa
-
You are here:
